Maryland Rep. Jamie Raskin announces cancer diagnosis
Maryland Democratic Congressman Jamie Raskin announced on Wednesday that he had been diagnosed with cancer, vowing to continue working through his treatment over the course of the next several months.
"After several days of tests, I have been diagnosed with Diffuse Large B Cell Lymphoma, which is a serious but curable form of cancer," Raskin wrote in a press release published Wednesday evening. "I am about to embark on a course of chemo-immunotherapy on an outpatient basis at Med Star Georgetown University Hospital and Lombardi Comprehensive Cancer Center. Prognosis for most people in my situation is excellent after four months of treatment."
Raskin, who rose to national prominence as both lead impeachment manager in the second Senate trial of Donald Trump as well as a member of Congress' Select Committee investigating Jan. 6, joked that although his planned course of chemo-immunotherapy would likely lead to hair loss and weight gain, he was "still holding out hope for the kind that causes hair gain and weight loss."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Raskin's announcement was met with well-wishes from some of the GOP's most partisan figures, with Reps Chip Roy of Texas, and Marjorie Taylor Greene of Georgia both sending him their regards shortly after his statement was released.
Raskin is set to become the Democrats' ranking member of the House Judiciary Committee in the coming congressional term.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Rafi Schwartz has worked as a politics writer at The Week since 2022, where he covers elections, Congress and the White House. He was previously a contributing writer with Mic focusing largely on politics, a senior writer with Splinter News, a staff writer for Fusion's news lab, and the managing editor of Heeb Magazine, a Jewish life and culture publication. Rafi's work has appeared in Rolling Stone, GOOD and The Forward, among others.
-
Grok in the crosshairs as EU launches deepfake porn probeIN THE SPOTLIGHT The European Union has officially begun investigating Elon Musk’s proprietary AI, as regulators zero in on Grok’s porn problem and its impact continent-wide
-
‘But being a “hot” country does not make you a good country’Instant Opinion Opinion, comment and editorials of the day
-
Why have homicide rates reportedly plummeted in the last year?Today’s Big Question There could be more to the story than politics
-
Is Alex Pretti shooting a turning point for Trump?Today’s Big Question Death of nurse at the hands of Ice officers could be ‘crucial’ moment for America
-
‘Dark woke’: what it means and how it might help DemocratsThe Explainer Some Democrats are embracing crasser rhetoric, respectability be damned
-
Can anyone stop Donald Trump?Today's Big Question US president ‘no longer cares what anybody thinks’ so how to counter his global strongman stance?
-
How realistic is the Democratic plan to retake the Senate this year?TODAY’S BIG QUESTION Schumer is growing bullish on his party’s odds in November — is it typical partisan optimism, or something more?
-
House approves ACA credits in rebuke to GOP leadersSpeed Read Seventeen GOP lawmakers joined all Democrats in the vote
-
Hegseth moves to demote Sen. Kelly over videospeed read Retired Navy fighter pilot Mark Kelly appeared in a video reminding military service members that they can ‘refuse illegal orders’
-
Trump says US ‘in charge’ of Venezuela after Maduro grabSpeed Read The American president claims the US will ‘run’ Venezuela for an unspecified amount of time, contradicting a statement from Secretary of State Marco Rubio
-
Jack Smith: Trump ‘caused’ Jan. 6 riotSpeed Read
